The company is aiming to operationalize its lithium spodumene concentrator in Wolfsberg, which will be the next significant source of lithium spodumene for European lithium-ion battery market, by 2027.

Sage will oversee corporate strategy and commercial development for Wolfsberg, and will focus on evaluating additional strategic assets in the critical metals space to be brought under the company’s banner.

“Critical Metals is at a pivotal juncture in our growth trajectory and development strategy following our recent listing on Nasdaq earlier this year,” Sage said in a statement. “This strategic transition of roles will better position us for future success both in Wolfsberg and more broadly.”